Difference between revisions of "Wang H, et al. Cell Oncol. (Dordr.) (2016) cited as Ref 469 in DOI: 10.1038/s41392-020-0110-5 (Q9732)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): 35-45, #quickstatements; #temporary_batch_1590074839150) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / Published In Name String | |||
| + | Cell Oncol. (Dordr.) | ||
| Property / Published In Name String: Cell Oncol. (Dordr.) / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 39 | ||
| Property / Volume: 39 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | HepG2 cells acquire stem cell-like characteristics after immune cell stimulation (English) | ||
| Property / title: HepG2 cells acquire stem cell-like characteristics after immune cell stimulation (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 35-45 | ||
| Property / Page(s): 35-45 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:42, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wang H, et al. Cell Oncol. (Dordr.) (2016) cited as Ref 469 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wang H
0 references
2016
0 references
Cell Oncol. (Dordr.)
0 references
39
0 references
HepG2 cells acquire stem cell-like characteristics after immune cell stimulation (English)
0 references
35-45
0 references
